Change is good. Health Technology Assessment itself is constituted of many change components starting from research, which is looking for evidence to change something, to decision-making, which is changing something from its previous state to a new one. With the half of 2017 gone by, many new change

Economic evaluation (EE) is a field that is increasingly needed in many countries to support health decision making for priority setting and resource allocation. Although the core concept of EE is simple it is a comparison of at least 2 interventions in terms of costs and benefits – the practicaliti

COVID-19 has been inevitably staying with us for almost a year and a half since the first outbreak. It induces us to seek for more knowledge in order to survive and control this harsh situation, not only from healthcare perspective but also economic and political ones. HTA is a great helping hand fo

The past 9th HTAsiaLink Annual Conference has been a big success, initiating the first hybrid conference in our HTAsiaLink history. However, unpredictable challenges still await, both existing and new coming issues. Omicron is one of them, provoking us to strive for more knowledge and evidence. As f

In the world that is full of unpredictable and countless number of uncertainties, it is a great challenge that we have to observe and adapt in order to overcome such swiftly shifting challenges. However, over the past three years, people around the world have been facing one of the most critic

The 10th HTAsiaLink Annual Conference is the first physical conference after the pandemic hit for HTAsiaLink network. Under the theme ‘The Role of HTA in the New Normal: Driving the post-COVID health systems through evidence-informed decisions,’ a broad range of discussions were sparked and would co

Details: The 11th HTAsiaLink Annual Conference took place in Putrajaya Malaysia, centered around the theme “Reshaping and Reshifting HTA in Navigating the Future Landscape”. Key discussions revolved around accelerating access to technologies, evaluating public health interventions and addressing ch

Human papillomavirus vaccine introduction in low and middle income countries: guidance on the use of cost-effectiveness models Mark Jit1, Nadia Demarteau2†, Elamin Elbasha3†, Gary Ginsberg4†, Jane Kim5†, Naiyana Praditsitthikorn6†, Edina Sinanovic7† and Raymond Hutubessy8* † Contributed equally 8

Government use licenses in Thailand: The power of evidence, civil movement and political leadership Suwit Wibulpolprasert1, Vichai Chokevivat2, Cecilia Oh3 and Inthira Yamabhai3* 3Health Intervention and Technology Assessment Program Abstract This paper attempts to describe and analyse t

Government use licenses in Thailand: an assessment of the health and economic impacts Inthira Yamabhai, Adun Mohara, Sripen Tantivess*, Kakanang Chaisiri and Yot Teerawattananon. Health Intervention and Technology Assessment Program (HITAP) Background Between 2006 and 2008, Thailand’s Mi